media

Markets

Market Nav

News Details

16/02/2024 11:58

Kabra Drugs Ltd. - Submission Of Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligations And Dis

Pursuant to Regulation 13(3) of SEBI (LODR) Regulation 2015, we hereby furnish below the statement of Investor Grievances for the quarter ended September 30, 2019.